InsidersTradesSigma
Follow the GRIFOLS, S.A. stock price and the full insider trade history of the company, a listed issuer based in Spain. Shares are quoted on the ES market, under the authority of CNMV. Operating in the Health Care sector, GRIFOLS, S.A. has recorded 30 reports. Market capitalisation: €6.7bn. The latest transaction was reported on 3 July 2026 (Other). Among the most active insiders: Raimon Grifols Roura. Every trade is accessible without an account.
30
Insider Decl.
n/a
Thresholds
€11m
15 ops.
Buy Volume
€2m
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate GRIFOLS, S.A. Buy (bullish), based on 12 analysts. Average price target: €14.51.
41Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,704 of 29,062 companies
56.8
score / 100
Value70
Quality43
FCF yld9.3%
Earn yld6.0%
EV/EBITDA9.9x
ROE6.9%
Gross mgn38%
Net mgn5.3%
Debt/EBITDA5.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 July 2026
Declarations30 total
7,679 shares0ShareXOFFISIN ES0171996087CNMV:2026020827
16,674 shares0ShareXOFFISIN ES0171996087CNMV:2025116273
735,923 shares@ €10.520.12% mcap100.0% of flowShareXOFFISIN ES0171996087CNMV:2025081179
8,000 shares0ShareXOFFISIN ES0171996087CNMV:2025077386
1,059 shares@ €8.670.0001% mcap2.3% of flowShareXMADISIN ES0171996087CNMV:2025070231
5,844 shares0ShareXOFFISIN ES0171996095CNMV:2025037404
4,750 shares@ €10.450.0008% mcap100.0% of flowShareEQTBISIN ES0171996087CNMV:2025033958
8,000 shares@ €10.810.0014% mcap23.8% of flowShareXMCEISIN ES0171996087CNMV:2025031309
6,110 shares@ €9.380.0009% mcap14.2% of flowShareEQTBISIN ES0171996087CNMV:2024141907
5,500 shares@ €9.170.0008% mcap100.0% of flowShareXMCEISIN ES0171996087CNMV:2024141514
9,178 shares@ €8.840.0013% mcap100.0% of flowShareXXXXISIN ES0171996087CNMV:2024080800
21,274 shares@ €5.420.0018% mcap31.7% of flowShareXXXXISIN ES0171996095CNMV:2024039929
21,274 shares@ €5.420.0018% mcap100.0% of flowShareXXXXISIN ES0171996095CNMV:2024039930
45,657 shares@ €7.410.0054% mcap83.6% of flowShareXXXXISIN ES0171996087CNMV:2024036632
24,700 shares@ €6.550.0026% mcap44.5% of flowShareXXXXISIN ES0171996087CNMV:2024035678
100,000 shares@ €6.600.011% mcap100.0% of flowShareXXXXISIN ES0171996087CNMV:2024035681
5,838 shares@ €15.410.0014% mcap9.1% of flowShareXXXXISIN ES0171996087CNMV:2024000082
106,000 shares0ShareXXXXISIN ES0171996087CNMV:2023112834
700,000 shares@ €12.840.14% mcap100.0% of flowShareXXXXISIN ES0171996087CNMV:2023075260
100,000 shares@ €8.960.014% mcap90.9% of flowShareXXXXISIN ES0171996087CNMV:2023075287
100,000 shares@ €8.960.014% mcap100.0% of flowShareXXXXISIN ES0171996087CNMV:2023075288
20,422 shares@ €10.2436.5% of flowShareXXXXISIN ES0171996095CNMV:2022033687
20,422 shares@ €10.2464.5% of flowShareXXXXISIN ES0171996095CNMV:2022033689
35,000 shares@ €16.22100.0% of flowShareXXXXISIN ES0171996087CNMV:2021151851
25 of 30 declarations
Acerca de GRIFOLS, S.A.
GRIFOLS, S.A. es una empresa española que se especializa en la producción de productos derivados del plasma y medicamentos para el tratamiento de enfermedades raras. Cotiza en el mercado de valores español, XMAD.